ABPI Board
As a member organisation, we are led by our members who are actively involved in all the core areas of our activity, as well as helping to form the strategy and direction for the ABPI.
The ABPI Board comprises of individuals who are elected by members to represent the industry; and up to five people who are co-opted by the Board. Elections commence every January for elected seats to ensure that the Board is fully representative and has access to the broadest range of skills and expertise possible.
Our current Board includes:
President – Susan Rienow, Country President of Pfizer |
|
Vice President – Jessamy Baird, Managing Director of Sanofi UK & Ireland |
-
AbbVie
-
Amgen
-
AstraZeneca
-
BMS
-
Gilead
-
GSK
-
Ipsen
-
Janssen
-
Jazz
-
Lilly
-
MSD
-
Merck
-
Novartis
-
Pfizer
-
Roche
-
Sanofi
-
Shionogi
-
Takeda
-
UCB
Last modified: 09 June 2023
Last reviewed: 09 June 2023